Skip to main content

Table 1 Baseline clinical characteristics of studied subjects

From: Evaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: a pilot prospective clinical trial

Baseline clinical characteristics

Number of subjects

17

Age (years)

24.35 ± 0.99

BMI

22.74 ± 0.58

Systolic BP (mmHg)

123.53 ± 2.70

Diastolic BP (mmHg)

77.94 ± 0.96

Serum creatinine (μmol/L)

86.76 ± 2.43

Serum glucose (mmol/L)

5.1 ± 0.09

Red blood cells (T/L)

5.1 ± 0.06

Hemoglobin (g/dL)

14.87 ± 0.15

Hematocrite (%)

43.76 ± 0.4

Platelets (G/L)

224.53 ± 9.62

Leukocytes (G/L)

5.75 ± 0.32

Polynuclear neutrophils (G/L)

2.87 ± 0.25

Polynuclear eosinophils (G/L)

0.16 ± 0.03

Polynuclear basophils (G/L)

0.02 ± 0.00

Lymphocytes (G/L)

2.15 ± 0.14

Monocytes (G/L)

0.54 ± 0.04

SGOT (IU/L)

25.65 ± 1.46

SGPT (IU/L)

25.89 ± 3.57

CK (IU/L)

137.88 ± 22.45

GGT (IU/L)

20.82 ± 1.63

  1. Data are presented as the mean ± SEM. BMI: Body Mass Index; BP: blood pressure; SGOT: serum glutamic oxaloacetic transaminase; SGPT: serum glutamic-pyruvic transaminase, CK: Creatine kinase, GGT: Gamma-glutamyl transpeptidase.